Why Bruker Stock Slumped Monday
(NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the closing bell, as investors didn't take kindly to a double miss on full-year guidance. Earlier in the trading session, Bruker dipped as much as 3.9%.
Bruker, which specializes in the supply of medical devices and scientific instruments, earned revenue of almost $861 million in its third quarter. This number was down 0.5% from the same period of 2024.
Image source: Getty Images.
Source Fool.com
Bruker Corp. Aktie
34,86 €
0,90 %
Die Community bevorzugt Bruker Corp. mit mehreren Buy-Einschätzungen und keinen Sell-Einschätzungen.
Eine Steigerung von über 20% ist für Bruker Corp. möglich, angesichts eines Kursziels von 45 € gegenüber 34.86 €.
